Chinese Journal of Hematology | 2019
抗CD38抗体Daratumumab治疗复发/难治性原发性轻链型淀粉样变二例报告并文献复习
Abstract
Anti-CD38 human antibody Daratumumab in the treatment of relapsed or refractory primary light chain amyloidosis:2 cases report and literatures review Gao Su, Zhang Congli, Li Jian, Yan Han, Zhang Bo, Hu Yu, Sun Chunyan Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China Corresponding author: Sun Chunyan, Email: [email protected]